Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins
The incidence of primary cutaneous melanoma continues to increase annually and is one of the most aggressive malignancies in humans and need to develop more novel non-surgical therapies.Autophagy and cathepsin B targeted therapy was reported to improve melanoma treatment.Cepharanthine (CEP), a natural alkaloid extracted from the genus Cephalophyllu